Research publications

Contribution of common infections to cardiovascular risk in HIV-positive individuals

Berquist V, Hoy JF, Trevillyan JM

(2017), AIDS Rev, 19(2), 72-80

HIV integration sites in latently infected cell lines

Symons J, Chopra A, Malatinkova E, De Spiegelaere W, Leary S, Cooper D, Abana CO, Rhodes A, Rezaei SD, Vandekerckhove L, Mallal S, Lewin SR, Cameron PU

(2017), Retrovirology, 14(1), 2

DOI: 10.1186/s12977-016-0325-2

HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment

Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR

(2017), AIDS, 31(15), 2035-52

DOI: 10.1097/QAD.0000000000001574

Sequence Control as a Powerful Tool for Improving the Selectivity of Antimicrobial Polymers

Kuroki A, Sangwan P, Qu Y, Peltier R, Sanchez-Cano C, Moat J, Dowson CG, Williams EGL, Locock KES, Hartlieb M, Perrier S

(2017), ACS Appl Mater Interfaces, 9(46), 40117-26

DOI: 10.1021/acsami.7b14996

Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia

Murray GL, Tsyganov K, Kostoulias XP, Bulach DM, Powell D, Creek DJ, Boyce JD, Paulsen IT, Peleg AY

(2017), J Infect Dis, 215 (Suppl 1), S52-7

DOI: 10.1093/infdis/jiw529

A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy

Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, Bretagne S, Melchers W, Mengoli C, Caliendo AM, Cogliati M, Debets-Ossenkopp Y, Gorton R, Hagen F, Halliday C, Hamal P, Harvey-Wood K, Jaton K, Johnson G, Kidd S, Lengerova M, Lass-Florl C, Linton C, Millon L, Morrissey CO, Paholcsek M, Talento AF, Ruhnke M, Willinger B, Donnelly JP, Loeffler J; EAPCRI

(2017), Aust Fam Physician, 46(4), 235-40

Living systematic reviews: 2. Combining human and machine effort

Thomas J, Noel-Storr A, Marshall I, Wallace B, McDonald S, Mavergames C, Glasziou P, Shemilt I, Synnot A, Turner T, Elliott J; Living Systematic Review Network

(2017), J Clin Epidemiol, 91, 31-7

DOI: 10.1016/j.jclinepi.2017.08.011

Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients

Neoh CF, Snell GI, Levvey B, Morrissey O, Slavin MA, Stewart K, Kong DCM

(2017), J Pharm Pract Res, 47(3), 228-35

DOI: 10.1002/jppr.1234

Determining the analytical specificity of PCR-based assays for the diagnosis of IA: what is Aspergillus?

Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, Bretagne S, Melchers W, Mengoli C, Caliendo AM, Cogliati M, Debets-Ossenkopp Y, Gorton R, Hagen F, Halliday C, Hamal P, Harvey-Wood K, Jaton K, Johnson G, Kidd S, Lengerova M, Lass-Florl C, Linton C, Millon L, Morrissey CO, Paholcsek M, Talento AF, Ruhnke M, Willinger B, Donnelly JP, Loeffler J; EAPCRI

(2017), Med Mycol, 55(4), 402-13

DOI: 10.1093/mmy/myw093

Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?

Macesic N, Morrissey CO, Liew D, Bohensky MA, Chen SC, Gilroy NM, Milliken ST, Szer J, Slavin MA

(2017), Med Mycol, 55(7), 705-12

DOI: 10.1093/mmy/myw141

Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy

To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, Chan C, Drummond GR, Sobey CG, Broughton BRS, Starkey MR, van der Sluis R, Lewin SR, Bozinovski S, O'Neill LAJ, Quach T, Porter CJH, Brooks DA, O'Leary JJ, Selemidis S

(2017), Nat Commun, 8(1), 69

DOI: 10.1038/s41467-017-00057-x

Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database

Puhr R, Wright ST, Hoy JF, Templeton DJ, Durier N, Matthews GV, Russell D, Law MG

(2017), Sex Health, 14(4), 345-354

DOI: 10.1071/SH16151

CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy

Petoumenos K, Choi JY, Hoy J, Kiertiburanakul S, Ng OT, Boyd M, Rajasuriar R, Law M; Australian HIV Observational Database; TREATAsia HIV Observational Database

(2017), Antivir Ther, 22(8), 659-68

DOI: 10.3851/IMP3155

Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network

Lau JS, Kiss C, Roberts E, Horne K, Korman TM, Woolley I

(2017), Ann Clin Microbiol Antimicrob, 16, 3

DOI: 10.1186/s12941-017-0180-6

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

Koelsch KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, Xu Y, Bailey M, Marks KH, Sasson SC, Taylor MS, Tantau R, Obeid S, Milner B, Morrissey O, Pinto AN, Suzuki K, Busch MP, Keating SM, Kaiser P, Yukl S, Wong JK, Hiener BM, Palmer S, Zaunders J, Post JJ, Chan DJ, Avery S, Milliken ST, Kelleher AD, Lewin SR, Cooper DA

(2017), J Acquir Immune Defic Syndr, 75(3), 328-37

DOI: 10.1097/QAI.0000000000001381

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

Hoy JF, Grund B, Roediger M, Schwartz AV, Shepherd J, Avihingsanon A, Badal-Faesen S, de Wit S, Jacoby S, La Rosa A, Pujari S, Schechter M, White D, Engen NW, Ensrud K, Aagaard PD, Carr A; INSIGHT START Bone Mineral Density Substudy Group

(2017), J Bone Miner Res, 32(9), 1945-55

DOI: 10.1002/jbmr.3183

A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy

Wade A, Draper B, Doyle J, Allard N, Grinzi P, Thompson A, Hellard M

(2017), Aust Fam Physician, 46(4), 235-40

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults

Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, RodrÃguez-Ba?o J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SYC, Turnidge J, Utili R, Webb SAR, Paterson DL

(2017), Clin Microbiol Infect, 23(8), 533-41

DOI: 10.1016/j.cmi.2016.10.023

Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015

Medland NA, Chow EPF, McMahon JH, Elliott JH, Hoy JF, Fairley CK

(2017), PLoS One, 12(5), e0177634

DOI: 10.1371/journal.pone.0177634

Outcomes following detection of low level plasma HIV RNA in HIV-infected patients previously virologically suppressed on antiretroviral therapy: a retrospective observational study

Warren AM, Cheng AC, Watson K, Lewin SR, Hoy JF

(2017), Sex Health, 14(3), 238-43

DOI: 10.1071/SH16165